Agenda

Please note that changes and additions to the agenda may occur. Stay informed by revisiting this page in the lead-up to the event.

08:30        Registration, Partnering Meetings & Networking in the Exhibition Hall

 

09:00        Welcome & Introduction
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

 

09:05        Enabling and Intensifying Manufacturing of Biologics
                      Véronique Chotteau, Professor in Mammalian Cell-Based Bioprocess Technology, KTH Royal Institute of Technology

 

09:30        In-House Development of a Protein-Based Biological Drug: A Next-Generation Botulinum Neuromodulator Product for the Aesthetic Market
                      Ulf Ståhl, Product Research Leader, Galderma

 

09:55        Coffee, Partnering Meetings & Networking in the Exhibition Hall

 

10:30        BRIDGE Sweden – Accelerating Biologics Development through National Collaboration
                       Alexandra Patriksson, Senior Manager, Testa Center
                       Klas Bratteby, Research Specialist, Karolinska Institutet
                       Niklas Berndt Thalén, Research Scientist, Drug Discovery and Development Platform, SciLifeLab Solna

 

10:55        To Be Announced

 

11:20        Karolinska ATMP Centre: Accelerating Translational Research into Clinical Application
                      Knut Steffensen, Director, Karolinska ATMP Center, Karolinska Institutet

 

11:45        Lunch, Partnering Meetings & Networking in the Exhibition Hall

 

12:45        Introducing Cell and Gene Therapies in Sweden – the Role of the New Therapies Council
                      Åsa Derolf, Chair of the New Therapies Council (NT-rådet)

 

13:10        The Price of Innovation: How Do We Ensure Access to Gene Therapy?
                      – New payment models are needed for life-changing rare disease therapies
                      Fredrik Sjöö, Head of Medical Affairs, Nordic Region, CSL Behring

 

13:35        Immune Checkpoint Induction by a Topical Oligonucleotide Therapy for Atopic Dermatitis
                      Anna-Lena Spetz, Chief Scientific Officer, TIRmed Pharma

 

14:00        Coffee, Partnering Meetings & Networking in the Exhibition Hall

 

14:30        CAR-T Cells – Swedish Experiences
                      Gunilla Enblad, Professor in Oncology, Uppsala University

 

14:55        Transplantation of Allogeneic Beta Cells with No Immunosuppression
                      Per-Ola Carlsson, Professor in Medical Cell Biology, Uppsala University

 

15:20        More info coming soon!
                      Olof Nord, CEO, ScandiBio Therapeutics

 

15:45        Summary & Conclusion
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

 

16:00        Flemingsberg Science Christmas Party
                      Food and drinks, music and entertainment, and more – included for everyone!
                      Read more and register here.